Bone tumor load (HR, 1.03 [95% CI: 1.01, 1.04];P < .001) and liver and soft-tissue PSMA-positivetumor volume (HR, 1.53 [95% CI: 1.10, 2.11; P = .011] and 1.48[95% CI: 1.00, 2.18; P = .048], respectively) were associatedwith reduced rPFS (Fig 3, Table 3). This evidence concerns the gene FOLH1 and bone neoplasm.